Scott Bowden
Impact in
- Hepatology top 0.2%
- Hepatitis C virus research
- Hepatitis Viruses Studies and Epidemiology
- Liver Disease and Transplantation
- Epidemiology top 0.2%
- Hepatitis B Virus Studies
- Liver Disease Diagnosis and Treatment
Papers in
- Epidemiology 70
- Hepatitis B Virus Studies 68
- Liver Disease Diagnosis and Treatment 15
- Hepatology 49
- Hepatitis C virus research 43
- Hepatitis Viruses Studies and Epidemiology 8
- Co-authors
- Stephen Locarnini (38 shared papers)George Lau (9 shared papers)Stephen Locarnini (8 shared papers)Sharon R. Lewin (18 shared papers)William E. Delaney (3 shared papers)Paul Desmond (10 shared papers)Zachary Goodman (2 shared papers)Karsten Wursthorn (2 shared papers)
- Journals
- Hepatology (10 papers)Journal of Hepatology (8 papers)Antiviral Therapy (5 papers)The Medical Journal of Australia (5 papers)Journal of Clinical Microbiology (4 papers)
- Partner nations
- AustraliaUnited StatesChina
In The Last Decade
Scott Bowden
87 papers receiving 4.3k citations
Scott Bowden's Hit Papers
Peers
Comparison fields: 5 of 104
- Hepatology 2.6k
- Epidemiology 3.6k
- Infectious Diseases 614
- Virology 157
- Biophysics 61
Countries citing papers authored by Scott Bowden
This map shows the geographic impact of Scott Bowden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott Bowden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott Bowden more than expected).
Fields of papers citing papers by Scott Bowden
This network shows the impact of papers produced by Scott Bowden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott Bowden. The network helps show where Scott Bowden may publish in the future.
Co-authors
The 25 scholars most cited alongside Scott Bowden, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 91 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy1 ☆ Hit paper breakdown → | 2004 | 751 |
| 2 | 2010 | 361 | |
| 3 | 2010 | 295 | |
| 4 | 2001 | 209 | |
| 5 | 2005 | 183 | |
| 6 | 2000 | 150 | |
| 7 | 1997 | 132 | |
| 8 | 2008 | 108 | |
| 9 | 2003 | 106 | |
| 10 | 2007 | 97 | |
| 11 | 1999 | 92 | |
| 12 | 2002 | 89 | |
| 13 | 2019 | 88 | |
| 14 | 2014 | 86 | |
| 15 | 2015 | 79 | |
| 16 | 1995 | 78 | |
| 17 | 2012 | 78 | |
| 18 | 2009 | 65 | |
| 19 | 2013 | 59 | |
| 20 | 2013 | 58 |
About Scott Bowden
Scott Bowden is a scholar working on Epidemiology, Hepatology, Infectious Diseases, Oncology and Immunology, having authored 91 papers that have together received 4.5k indexed citations. Recurring topics across this work include Hepatitis B Virus Studies (68 papers), Hepatitis C virus research (43 papers), Liver Disease Diagnosis and Treatment (15 papers), Hepatitis Viruses Studies and Epidemiology (8 papers), HIV/AIDS drug development and treatment (7 papers), Polyomavirus and related diseases (6 papers), Viral gastroenteritis research and epidemiology (5 papers) and Parvovirus B19 Infection Studies (3 papers). The work is most often cited by research in Hepatology (2.6k citations), Epidemiology (3.6k citations), Infectious Diseases (614 citations), Virology (157 citations) and Biophysics (61 citations). Scott Bowden has collaborated with scholars based in Australia, United States and China. Frequent co-authors include Stephen Locarnini, George Lau, Stephen Locarnini, Sharon R. Lewin, William E. Delaney, Paul Desmond, Zachary Goodman, Karsten Wursthorn, Christian Trépo and Jörg Petersen. Their work appears in journals such as Hepatology, Journal of Hepatology, Antiviral Therapy, The Medical Journal of Australia and Journal of Clinical Microbiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.